Immunocore

📍 Abingdon, United Kingdom🗓 Founded 2008👥 549 employees💰 Last funded 2020
Biotechnology Research🌐 immunocore.com
Website LinkedIn
Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr
3
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Belgium
1
United States
1
United Kingdom
1
Investor activity2018–2020 · investors recorded per year
2018220201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Immunocore?
Immunocore has 3 investors on record on gritt.io and 1 late-stage investors.
When did Immunocore last raise funding?
The most recent investment in Immunocore recorded on gritt.io was in 2020.
When was Immunocore founded?
Immunocore was founded in 2008.
What industry is Immunocore in?
Immunocore operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Immunocore based?
Immunocore is headquartered in Abingdon, United Kingdom.